OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug Interactions Affecting Antiarrhythmic Drug Use
Philip L. Mar, Piotr J. Horbal, Mina K. Chung, et al.
Circulation Arrhythmia and Electrophysiology (2022) Vol. 15, Iss. 5
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
José A. Joglar, Mina K. Chung, Anastasia L. Armbruster, et al.
Journal of the American College of Cardiology (2023) Vol. 83, Iss. 1, pp. 109-279
Open Access | Times Cited: 283

Managing novel therapies and concomitant medications in chronic lymphocytic leukemia: key challenges
Sofija Kozarac, Jelena Ivanović, Milena Mitrović, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access

Cardiac Electrophysiology and Pharmacology of Arrhythmia
Chad R. Frasier
Elsevier eBooks (2025)
Closed Access

Population pharmacokinetic analysis of the interaction of digoxin with N‐desethylamiodarone in patients with atrial fibrillation and heart failure
Toshinori Hirai, Hidefumi Kasai, Tsuyoshi Shiga
British Journal of Clinical Pharmacology (2025)
Closed Access

Proarrhythmia associated with antiarrhythmic drugs: a comprehensive disproportionality analysis of the FDA adverse event reporting system
Feifei Wang, Bingfeng Zhou, Hongwei Sun, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10

Cardiac Arrhythmias and Autonomic Dysfunction Associated With COVID-19: A Scientific Statement From the American Heart Association
Rakesh Gopinathannair, Brian Olshansky, Mina K. Chung, et al.
Circulation (2024) Vol. 150, Iss. 21
Closed Access | Times Cited: 2

A rare case of flecainide-induced encephalopathy
Elisabeth Wong, Michael Wu
HeartRhythm Case Reports (2023) Vol. 10, Iss. 3, pp. 201-202
Open Access | Times Cited: 4

Antiarrhythmic drugs in the present day
Raphael Allgaier, David Duncker
Deleted Journal (2024) Vol. 65, Iss. 8, pp. 762-769
Closed Access | Times Cited: 1

Motnje srčnega ritma zaradi hiperdigitalisnega stanja in akutna obravnava zastrupljencev z digoksinom
Mark Jovanović, Miran Brvar
Slovenian Medical Journal (2024) Vol. 93, Iss. 7-8, pp. 272-288
Open Access | Times Cited: 1

Drug–Drug Interactions in Nosocomial Infections: An Updated Review for Clinicians
Sorina Hîncu, Miruna-Maria Apetroaei, G. Stefan, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1137-1137
Open Access | Times Cited: 1

It is a fine line with flecainide: A case of flecainide toxicity in a pediatric patient
Aura Daniella Santi-Turchi, Keerthana Banala, Michelle Jadotte, et al.
Progress in Pediatric Cardiology (2024) Vol. 75, pp. 101761-101761
Closed Access | Times Cited: 1

Adverse reactions to antiarrhythmic drugs
Ungjeong Do
Cardiovascular Prevention and Pharmacotherapy (2023) Vol. 5, Iss. 1, pp. 1-14
Open Access | Times Cited: 3

Risk Factors for Potential Drug-Drug Interactions in Patients on Chronic Peritoneal Dialysis
Milorad Stojadinović, Mirjana Laušević, Iman Assi Milošević, et al.
Pharmacology (2024) Vol. 109, Iss. 3, pp. 147-155
Closed Access

Distinct electrocardiographic findings of a drug-drug interaction
Yubin Zhang, Tong Liu, Gan‐Xin Yan
BMJ (2024), pp. e077088-e077088
Closed Access

PERSPECTIVAS E DESAFIOS DAS DROGAS ANTIARRÍTMICAS: MITIGANDO O RISCO DE PROARRITMIA
Ana Paula Porto Campos e Campos, Bárbara Aparecida de Souza e Souza, Diego Farias Costa, et al.
EPITAYA eBooks (2024), pp. 13-40
Open Access

Drug-Drug Interactions in Hospitalized Urological Patients: A Retrospective Cohort Study
Ivan R Milovanovic, Ana V. Pejčić
Pharmacology (2024), pp. 1-11
Closed Access

Supporting Patients with Nontuberculous Mycobacterial Pulmonary Disease: Ensuring Best Practice in UK Healthcare Settings
Toby Capstick, Rhys Hurst, Jennie Keane, et al.
Pharmacy (2024) Vol. 12, Iss. 4, pp. 126-126
Open Access

Amiodarone Therapy: Updated Practical Insights
Victoriţa Şorodoc, Lucia Indrei, Catinca Dobroghii, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 20, pp. 6094-6094
Open Access

Antipsychotic drugs and their possible cardiovascular adverse effects – literature review
Alicja Gładysz, Maciej Zamorski, Agata Stebel, et al.
Current Problems of Psychiatry (2024) Vol. 25, pp. 215-225
Open Access

Nicorandil as a promising therapeutic option for ventricular arrhythmia: A case report and review of literature
Lingyu Bai, Ming Zhao, Karen Ma
World Journal of Cardiology (2024) Vol. 16, Iss. 12, pp. 768-775
Closed Access

Reassessing Ivabradine: Potential Benefits and Risks in Atrial Fibrillation Therapy
Dorsa Alijanzadeh, Sharareh Moghim, P Zaránd, et al.
Cardiovascular Drugs and Therapy (2024)
Closed Access

Drug Interactions of Antiarrhythmic Drugs
Ricardo Caballero, Eva Delpón, Juan Tamargo
(2024), pp. 311-341
Closed Access

Page 1 - Next Page

Scroll to top